Damora Therapeutics appoints Jennifer Jarrett CEO

Damora Therapeutics has announced the appointment of Jennifer Jarrett as its new Chief Executive Officer. This leadership change marks a significant moment for the company as it navigates its strategic path forward. Jarrett's extensive experience in the biotechnology sector is expected to bring fresh perspectives and drive innovation within Damora Therapeutics. The company anticipates that her leadership will be instrumental in advancing its pipeline and achieving key milestones in the competitive pharmaceutical landscape.